FREQUENCY OF ELECTROLYTE ABNORMALITIES IN PATIENTS WITH DECOMPENSATED CHRONIC LIVER DISEASE

M ULLAH; . MAAZ; MF RASHID; I ALI; M NIAZ; M KAMRAN

doi:10.54112/bcsrj.v2024i1.1364

Authors

M ULLAH Lady Reading Hospital Peshawar, Pakistan
. MAAZ District Headquarters Hospital, Lakki Marwat, Pakistan
MF RASHID Al Aleem Medical College and Gulab Devi Hospital Lahore, Pakistan
I ALI Bahria University Medical College Islamabad, Pakistan
M NIAZ Department Of Internal Medicine, Paf Hospital Mushaf Sargodha, Pakistan
M KAMRAN Fauji Foundation Hospital Malakand Batkhela, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1364

Keywords:

Electrolyte Imbalance Liver Diseases, Chronic Hyponatremia Hypokalemia Cross-Sectional Studies

Abstract

Electrolyte abnormalities, particularly those involving sodium, potassium, magnesium, calcium, and phosphate, are commonly observed in patients with decompensated chronic liver disease (DCLD). Objective: The basic aim of the study is to find the frequency of electrolyte abnormalities in patients with decompensated chronic liver disease. Methodology: This cross-sectional observational study was carried out at Lady Reading Hospital, Peshawar, from January 2024 to May 2024. The study included a total of 235 patients diagnosed with decompensated chronic liver disease. Patients aged >18 years with a confirmed diagnosis of chronic liver disease in the decompensated stage, characterized by complications such as ascites, variceal bleeding, or hepatic encephalopathy. Results: Data were collected from 235 patients with a mean age of 52.3 ± 10.4 years, with a male predominance (59.6%). Common comorbidities among participants included hypertension (45.5%), diabetes mellitus (30.6%), and chronic hepatitis C infection (60.9%). These underlying conditions highlight the complex health profile of patients with decompensated chronic liver disease, which may further influence electrolyte imbalances and overall disease outcomes. Sodium levels deviated from the normal range in 67.2% of patients, with hyponatremia observed in 60.9% (mean sodium level 132.5 ± 6.3 mmol/L) and hypernatremia in 6.4%. Potassium abnormalities were found in 49.4% of patients, with 37.0% exhibiting hypokalemia and 12.3% showing hyperkalemia (mean potassium level 4.0 ± 0.7 mmol/L). Hypocalcemia was prevalent in 44.3% of patients, with an average calcium level of 8.0 ± 0.6 mg/dL. Hypomagnesemia and hypophosphatemia were less common but still present in 25.1% and 20.4% of patients, respectively. These abnormalities underscore the need for vigilant electrolyte monitoring in DCLD patients. Conclusion: It is concluded that electrolyte abnormalities are highly prevalent in patients with decompensated chronic liver disease and are strongly associated with increased disease severity, complications, and poor outcomes.

Downloads

Download data is not yet available.

References

Singh Y, Nagar D, Singh M, Maroof M. Study of electrolyte disturbance in chronic liver disease patients attending a hospital in Kumaon region. J Family Med Prim Care. 2022 Aug;11(8):4479-4482. doi: 10.4103/jfmpc.jfmpc_404_22. Epub 2022 Aug 30. PMID: 36353013; PMCID: PMC9638604.

Hassan ZBA, Kadum J. Electrolytes disturbance in liver cirrhosis. Graduation thesis, Al-Nahrain College of Medicine, Iraq; 2019. Available from: https://www.colmed-alnahrain.edu.iq/upload/res/884.pdf.

Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: A clinical update. Endocr Connections. 2018;7–46. doi: 10.1530/EC-18-0109.

Kuchay MS, Mishra SK, Farooqui KJ, Bansal B, Wasir JS, Mithal A. Hypercalcemia of advanced chronic liver disease: A forgotten clinical entity! Clin Cases Miner Bone Metab. 2016; 13:15–8. doi: 10.11138/ccmbm/2016.13.1.015

Devrajani BR, Shah SZ, Devrajani T, Kumar D. Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad. J Pak Med Assoc. 2009; 59:683.

Kashyap C, Borkotoki S, Dutta RK. Study of serum sodium and potassium level in patients with alcoholic liver disease attending Jorhat Medical College Hospital—A hospital-based study. Int J Health Sci Res. 2016; 6:113–6.

Mumtaz K, Ahmed US, Abid S, Baig N, Hamid S, Jafri W. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010; 20:514–8.

Almani SA, Memon AS, Memon AI, Shah MI, Rahpoto MQ, Solangi R. Cirrhosis of liver: Etiological factors, complications and prognosis. JLUMHS. 2008; 2:61–6.

Yan GZ, Duan YY, Ruan LT, Cao TS, Yuan LJ, Yang YL. Non-invasive quantitative testing of liver function using ultrasonography in patients with cirrhosis. Hepatogastroentrology. 2006; 53:15–20.

Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, et al. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol. 2012; 57:274–80. doi: 10.1016/j.jhep.2012.03.018.

Younas A, Riaz J, Chughtai T, Maqsood H, Saim M, Qazi S, et al. Hyponatremia and its correlation with hepatic encephalopathy and severity of liver disease. Cureus. 2021; 13:13175. doi: 10.7759/cureus.13175.

Fromme M, Strnad P. Pathophysiology of chronic liver disease development. Int J Mol Sci. 2022;23(6):3385. doi:10.3390/ijms23063385.

Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol. 2021;75 Suppl 1. doi:10.1016/j.jhep.2021.01.002.

Perez IC, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by step: Managing the complications of cirrhosis. Hepat Med. 2021; 13:45-57. doi:10.2147/HMER.S278032

Kim Y, Kim K, Jang I. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study. Medicine (Baltimore). 2019;98(45). doi:10.1097/MD.0000000000017862.

Al-Sofyani KA. Prevalence and clinical significance of hyponatremia in pediatric intensive care. J Pediatr Intensive Care. 2019;8(3):130-137.

Wu SL, Zheng YX, Tian ZW, Chen MS, Tan HZ. Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy. World J Clin Cases. 2018;6(15):995-1006. doi:10.12998/wjcc.v6.i15.995.

Barakat AA, Metwaly AA, Nasr FM, El-Ghannam M, El-Talkawy MD, Taleb HA. Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis. Electron Physician. 2015;7(6):1349-1358. doi:10.14661/1349

Qaiser MA, Baig MA, Syed IA, Shah SH, Butt N, Najmi F. Severity of hyponatremia and its influence on various complications of decompensated chronic liver disease. Pak J Med Health Sci. 2022;16(11):878-880.

Kogiso T, Kobayashi M, Yamamoto K. The outcome of cirrhotic patients with ascites is improved by the normalization of the serum sodium level by tolvaptan. Intern Med. 2017;56(22):2993-3001.